文献速递MDS 与骨髓增殖性肿瘤白血病

EZH2/H3K27me3下调CXCL10影响CD8+ T细胞耗竭参与骨髓增生异常综合征向急性髓系白血病转化的机制

The mechanism of EZH2/H3K27me3 downregulating CXCL10 to affect CD8+ T cell exhaustion to participate in the transformation from myelodysplastic syndrome to acute myeloid leukaemia.
PubMed 文献 · Br J Haematol · 2025-04-09

研究探索EZH2/H3K27me3下调CXCL10影响CD8+ T细胞耗竭、参与骨髓增生异常综合征(MDS)向急性髓系白血病(AML)转化的机制。NHD13小鼠接受GSK126(EZH2抑制剂)和CXCL10中和抗体处理,SKM-1细胞与CD8+ T细胞共培养。EZH2抑制上调CXCL10,减缓MDS向AML转化并延迟CD8+ T细胞耗竭。

要点

  • EZH2抑制上调CXCL10,减缓NHD13小鼠MDS向AML转化并延迟CD8+ T细胞耗竭。
  • CXCL10中和抗体通过EZH2加速AML转化。
  • EZH2介导的H3K27me3抑制CXCL10转录和分泌。

核心结论

  • EZH2/H3K27me3下调CXCL10促进CD8+ T细胞耗竭,加速MDS向AML转化。

研究设计与样本

  • NHD13小鼠接受GSK126(EZH2抑制剂)和CXCL10中和抗体处理,检测转化时间、血细胞计数和CD8+ T细胞。
  • SKM-1细胞经短发夹EZH2、过表达EZH2、GSK126和CXCL10处理,与CD8+ T细胞共培养。

主要发现

  • 体内EZH2抑制上调CXCL10,减缓MDS向AML转化并延迟CD8+ T细胞耗竭。
  • EZH2抑制升高NHD13小鼠外周血细胞、减轻脾肿大、减少CD8+ T细胞、升高CD8+ T细胞毒性并减轻CD8+ T细胞耗竭。
  • CXCL10中和抗体通过EZH2加速AML转化。
  • 体外EZH2过表达促进CD8+ T细胞耗竭和SKM-1细胞恶性行为。
  • EZH2介导的H3K27me3抑制CXCL10转录和分泌。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML) link to unfavourable prognoses. We explored the mechanism of enhancer of zeste homologue 2/histone H3 of lysine 27 (EZH2/H3K27me3) downregulating C-X-C motif chemokine 10 (CXCL10) to affect CD8+ T-cell exhaustion, participating in MDS-to-AML transformation. NHD13 mice were treated with GSK126 (EZH2 inhibitor) and CXCL10 neutralizing antibody, with transformation time, blood cell counts and CD8+ T cell determined. SKM-1 cells treated with short hairpin-EZH2, overexpressing-EZH2, GSK126 and CXCL10 were co-cultured with CD8+ T cells. EZH2, CXCL10, H3K27me3 and EZH2 levels and EZH2 enzyme activity were assessed. CD8+ T-cell cytotoxicity, exhaustion, apoptosis and SKM-1 cell malignant behaviours were evaluated. In vivo, EZH2 inhibition upregulated CXCL10, decelerating MDS to AML transformation and delaying CD8+ T-cell exhaustion. EZH2 inhibition elevated peripheral blood cells, alleviated splenomegaly, reduced CD8+ T cells, elevated CD8+ T cytotoxicity and abated CD8+ T-cell exhaustion in NHD13 mice. CXCL10 neutralizing antibody accelerated AML transformation by inhibiting CD8+ T-cell exhaustion via EZH2. In vitro, EZH2 overexpression facilitated CD8+ T-cell exhaustion and SKM-1 cell malignant behaviours. EZH2-mediated H3K27me3 curbed CXCL10 transcription and secretion. Collectively, EZH2/H3K27me3 downregulates CXCL10 to facilitate CD8+ T-cell exhaustion, accelerating transformation from MDS to AML.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Zheng Z, Wang W, Feng M, et al. The mechanism of EZH2/H3K27me3 downregulating CXCL10 to affect CD8+ T cell exhaustion to participate in the transformation from myelodysplastic syndrome to acute myeloid leukaemia. Br J Haematol. 2025. PMID: 40201935. doi:10.1111/bjh.20066

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。